Pancreatic β-cell tRNA hypomethylation and fragmentation link TRMT10A deficiency with diabetes
Year: 2018
Type: article
Abstract: Transfer RNAs (tRNAs) are non-coding RNA molecules essential for protein synthesis. Post-transcriptionally they are heavily modified to improve their function, folding and stability. Intronic polymorphisms in CDKAL1, a tRNA methylthiotransferase, are associated with increased type 2 diabetes risk. Loss-of-function mutations in TRMT10A, a tRNA methyltransferase, are a monogenic cause of early onset diabetes and microcephaly. Here we confirm the role of TRMT10A as a guanosine 9 tRNA methyltransferase, and identify tRNAGln and tRNAiMeth as two of its targets. Using RNA interference and induced pluripotent stem cell-derived pancreatic β-like cells from healthy controls and TRMT10A-deficient patients we demonstrate that TRMT10A deficiency induces oxidative stress and triggers the intrinsic pathway of apoptosis in β-cells. We show that tRNA guanosine 9 hypomethylation leads to tRNAGln fragmentation and that 5'-tRNAGln fragments mediate TRMT10A deficiency-induced β-cell death. This study unmasks tRNA hypomethylation and fragmentation as a hitherto unknown mechanism of pancreatic β-cell demise relevant to monogenic and polygenic forms of diabetes.
Source: Nucleic Acids Research
DOI: 10.1093/nar/gky839
Authors: Cristina Cosentino, Sanna Toivonen, Esteban Diaz Villamil, Mohamed Atta, Jean-Luc Ravanat, Stéphane Demine, Andrea Alex Schiavo, Nathalie Pachera, Jean-Philippe Deglasse, Jean-Christophe Jonas, Diego Balboa, Timo Otonkoski, Ewan R Pearson, Piero Marchetti, Décio L Eizirik, Miriam Cnop, Mariana Igoillo-Esteve
Institutions: Université Libre de Bruxelles, Commissariat à l'Énergie Atomique et aux Énergies Alternatives, CEA Grenoble, Laboratoire de Chimie et Biologie des Métaux, Centre National de la Recherche Scientifique, Institut Nanosciences et Cryogénie, Systèmes Moléculaires et nanoMatériaux pour l'Énergie et la Santé, Université Grenoble Alpes, UCLouvain, University of Helsinki, Helsinki University Hospital, Helsinki Children's Hospital, Ninewells Hospital, University of Pisa, Erasmus Hospital
Language: English
Topic: RNA modifications and cancer
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,992
Funders: Scientific Education and Research Institute, Wellcome Trust, European Federation of Pharmaceutical Industries and Associations, European Commission, European Foundation for the Study of Diabetes, Fonds De La Recherche Scientifique - FNRS, Innoviris, Université Paris Descartes, Novo Nordisk Fonden, Universitatea "Lucian Blaga" din Sibiu, Horizon 2020 Framework Programme, Staatssekretariat für Bildung, Forschung und Innovation, Erasmus+, ULB Center for Diabetes Research
Awards: G1806123798, Development of a systems biomedicine approach for risk identification, prevention and treatment of type 2 diabetes, G4284976464, Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification - Sofia ref.: 115881, Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification, G5893854107, G7549142150, G8041914798, Stratified medicine in Type 2 diabetes: Insights from the study of drug response., G8999935834
OpenAlex ID: W2891388080
